Mechanistically, loss of Klk1 promoted extracellular matrix (ECM) remodeling by upregulating Mmp2, Mmp9, Fap, decorin, and β‐catenin, thereby promoting epithelial‐mesenchymal transition and tumor progression. The gene discussed is MMP9; the disease is neoplasm.